Aug 19, 2026
New genomic studies show a practical recall-by-genotype strategy for psychiatry, shared genetic liability across psychiatric and physical conditions, and improved disease prediction using disease-history trajectories.
Aug 08, 2026
Adia Med has submitted an IRB study of AdiaVita for lower back pain and launched a redesigned website. The placebo-controlled crossover trial will enroll about 100 participants; an ASD study is also recruiting.
Jun 14, 2026
In vivo base editing corrected the CHD3 p.R1025W mutation in a mouse model of Snijders Blok–Campeau syndrome, restoring protein levels and rescuing behavioural abnormalities. Intrathecal AAV delivery in nonhuman primates supported translational feasibility.
Jul 23, 2026
Transcripta Bio raised $24M backed by Mayo Clinic and Omnimed for AI-driven neurological and neuromuscular therapies. The funds will support IND-enabling studies and clinical preparation for ASD and FSHD programs.
Jun 26, 2026
Studies reveal context-dependent genetic effects in psychiatric disorders, reassuring evidence on prenatal antidepressant use, and findings on parental depression timing, diagnostic interview reliability, and rising self-diagnosis.
Mar 23, 2026
A study of nearly 70,000 children found girls exposed to SARS-CoV-2 infection in utero had a 44% increased risk of autism spectrum disorder. The research showed 3.97% of pregnant women had COVID-19 infection, with most cases occurring in the third trimester. No increased risk was observed for boys or for speech/language and motor delays overall.
Feb 16, 2026
The U.S. Food and Drug Administration has approved an Investigational New Drug application for FRF-001, a viral gene therapy for FOXG1 syndrome developed at the University at Buffalo. The first-in-human trial will be independently sponsored by the FOXG1 Research Foundation.
Feb 19, 2026
Scientists developed Ribo-STAMP technology to map protein production across nearly 20,000 individual mouse brain cells, revealing unexpected differences in how memory neurons translate proteins and potential insights into neurological disorders.